Hyperinsulinism – Life with Disease

Go back

Hyperinsulinism is a rare but serious condition where the pancreas produces too much insulin, causing dangerously low blood sugar levels that can threaten brain development and overall health, particularly in babies and young children.

Prognosis and Expected Outcomes

Understanding what lies ahead when a child is diagnosed with hyperinsulinism can be emotionally overwhelming for families. The outlook for children with this condition depends largely on how quickly it is recognized and how well blood sugar levels can be controlled during the critical early months and years of life[1].

The severity and duration of hypoglycemic episodes—periods when blood sugar drops too low—are the main factors that influence long-term outcomes. When hypoglycemia occurs, the brain is deprived of glucose, which is its primary fuel source. Because insulin also blocks the body’s ability to use alternative fuels like ketones, children with hyperinsulinism face a particularly high risk of brain injury compared to children with low blood sugar from other causes[6]. This makes prompt diagnosis and aggressive treatment absolutely essential.

When hyperinsulinism is diagnosed and treated early, before repeated or prolonged episodes of severe hypoglycemia occur, many children can develop normally. Studies show that with appropriate management, most children can achieve a normal range of cognitive, emotional, and social skills[12]. However, if diagnosis is delayed or blood sugar control remains poor despite treatment, children may experience permanent neurological damage, which can manifest as developmental delays, learning disabilities, motor difficulties, or even epilepsy and cerebral palsy[7].

For certain forms of hyperinsulinism, particularly focal hyperinsulinism where only a small area of the pancreas is affected, surgical removal of that specific area can result in a complete cure. Advances in imaging technology, specifically a specialized scan called an 18F-DOPA PET scan, have made it possible to identify these focal lesions with greater accuracy[10]. Children who undergo successful focal lesion removal typically have excellent long-term outcomes and no longer require medication.

The prognosis for children with diffuse hyperinsulinism—where the entire pancreas is involved—is more variable. Some respond well to medications and may eventually outgrow the condition after several years of treatment, while others require more intensive management or even surgery[11]. Clinical remission, where medications can be stopped entirely, has been reported in some cases after months or years of consistent treatment, though this is not guaranteed for everyone[12].

⚠️ Important
Infants with hyperinsulinism are at higher risk for brain damage than infants with low blood sugar from other causes. This is because insulin not only lowers glucose but also prevents the body from producing ketones, which are alternative fuels the brain can use during periods of low blood sugar. Without either fuel source, brain cells are left vulnerable to permanent injury.

Natural Progression Without Treatment

If hyperinsulinism goes unrecognized or untreated, the consequences can be severe and progressive. Newborns and infants with this condition will experience frequent episodes of dangerously low blood sugar. Initially, these episodes may present with subtle symptoms such as poor feeding, lethargy, excessive sleepiness, or irritability—signs that are unfortunately easy to mistake for typical newborn behavior[4].

As hypoglycemia persists or worsens, symptoms become more alarming. Infants may develop seizures, stop breathing, or fall into a coma[4]. Each hypoglycemic episode represents a period when the brain is starved of the energy it needs to function and develop properly. The cumulative effect of repeated or prolonged episodes leads to irreversible brain damage.

The natural history of untreated hyperinsulinism depends somewhat on the underlying cause. In rare cases of transient hyperinsulinism—which can occur in premature babies, babies born to mothers with diabetes, or those who experienced stress during birth—the condition may resolve on its own within weeks to months as the baby matures[8]. However, genetic forms of hyperinsulinism, which account for the majority of cases, do not resolve spontaneously and will persist throughout life if left untreated[2].

Without intervention, children with persistent hyperinsulinism will continue to have unpredictable drops in blood sugar, especially during periods of fasting such as overnight or between meals. These children cannot safely skip feedings or go without food for normal lengths of time. The ongoing deprivation of glucose to the brain results in progressive neurological deterioration, affecting motor skills, cognition, speech, and behavior[1].

Possible Complications

Hyperinsulinism can lead to a range of serious complications, some of which may appear unexpectedly or develop gradually over time. The most significant and immediate complication is hypoglycemic brain injury. When blood sugar levels fall below what the brain needs to function—generally below 60 milligrams per deciliter—brain cells begin to suffer[6]. Repeated or severe hypoglycemia can cause permanent damage to areas of the brain responsible for movement, thinking, memory, and behavior.

Children who have experienced significant hypoglycemic episodes may develop epilepsy, a seizure disorder that can persist even after blood sugar control improves. They may also show signs of cerebral palsy, a group of disorders affecting movement and posture caused by damage to the developing brain[7]. Learning disabilities, attention problems, and delays in reaching developmental milestones such as sitting, walking, or talking are also common in children whose hyperinsulinism was not controlled early enough.

For children who undergo surgery to remove part or most of the pancreas—a treatment option when medications fail—there are additional potential complications. A near-total pancreatectomy, where most of the pancreas is removed, carries the risk of either persistent hypoglycemia if not enough tissue is removed, or the development of diabetes mellitus requiring lifelong insulin injections if too much is removed[2]. Finding the right balance is challenging, and some children may end up with diabetes as a trade-off for eliminating dangerous hypoglycemia.

Long-term medical treatment with medications such as octreotide, a somatostatin analogue used when other treatments fail, can cause its own set of complications. Some children develop tachyphylaxis, where the medication becomes less effective over time, requiring dose adjustments or alternative therapies[12]. Although rare, there have been concerns about persistent growth deceleration in children on long-term octreotide therapy, though more recent studies suggest this risk affects fewer than 5 percent of patients[12].

Other medications used to manage hyperinsulinism can also have side effects. Diazoxide, the most commonly used drug, can cause fluid retention, increased heart rate, and excessive hair growth, though severe side effects are uncommon[12]. Heart failure has been reported in a small percentage of children taking diazoxide, though the causal relationship remains uncertain.

Impact on Daily Life

Living with hyperinsulinism requires significant adjustments to daily routines, affecting not only the child but the entire family. For infants and young children with this condition, maintaining stable blood sugar becomes the central focus of every day. Parents must ensure their child receives frequent feedings, often every two to three hours around the clock, to prevent blood sugar from dropping too low[6]. This means disrupted sleep for caregivers and constant vigilance.

Many children with hyperinsulinism cannot safely go without food for the length of time that healthy children can tolerate. A healthy baby or toddler can typically fast for six hours—the equivalent of skipping one feeding—without developing hypoglycemia. For a child with hyperinsulinism, even a missed meal or a slightly delayed feeding can trigger a dangerous drop in blood sugar[6]. This makes normal activities such as traveling, attending daycare, or simply running errands more complicated and stressful.

Some children require continuous feeding through a gastric feeding tube, a tube placed through the nose or directly into the stomach that delivers nutrition throughout the day and night. While this ensures consistent blood sugar control, it also means the child is tethered to a feeding pump, limiting mobility and making typical childhood play more challenging[18]. Parents must learn to manage the feeding equipment, troubleshoot problems, and coordinate with medical supply companies.

For older children who are managing their condition with medication rather than surgery, there are additional considerations. They may need to check their blood sugar levels multiple times per day using finger-stick glucose meters or wear continuous glucose monitoring devices that track levels in real time[1]. While these technologies reduce anxiety by providing constant information, they also serve as a daily reminder of the condition and can make children feel different from their peers.

The emotional and psychological impact of hyperinsulinism should not be underestimated. Parents often experience significant anxiety and fear, particularly after witnessing their child experience a seizure or other severe hypoglycemic event. The constant need to monitor and respond to blood sugar levels can lead to exhaustion and feelings of being overwhelmed[14]. Siblings may feel neglected as parents’ attention is necessarily focused on the child with hyperinsulinism.

Children who have experienced neurological complications from hypoglycemia may face additional challenges in school, requiring special education services, physical therapy, occupational therapy, or speech therapy. These needs place further demands on families’ time and resources and can affect the child’s self-esteem and social relationships.

⚠️ Important
Before bringing a child with hyperinsulinism home from the hospital, healthcare teams typically perform a short fasting study lasting six to eight hours to ensure the child can safely tolerate a missed or inadequate feeding. This test helps families understand their child’s limits and reduces the risk of dangerous hypoglycemia at home.

Support for Families Considering Clinical Trials

For families navigating hyperinsulinism, understanding the role of clinical trials can be empowering. Clinical trials are research studies that test new treatments, medications, or diagnostic approaches to see if they are safe and effective. For a rare condition like hyperinsulinism, where treatment options remain limited, clinical trials may offer access to promising new therapies that are not yet widely available[11].

Families should know that participation in clinical trials is completely voluntary. Researchers are required to explain the purpose of the study, what will be done, potential benefits and risks, and any alternative treatments available. Parents have the right to ask questions, take time to consider the decision, and withdraw from a study at any time without affecting their child’s regular medical care.

When considering a clinical trial for hyperinsulinism, families may want to ask their healthcare team several important questions: What is the trial trying to learn? What treatments or procedures will my child receive? How long will the trial last? What are the possible risks and benefits? Will my child still receive standard care? Are there costs involved, and will insurance cover participation?

Relatives and family members can provide crucial support by helping parents research available trials, accompanying them to appointments, or simply listening as they work through the decision. Grandparents, aunts, uncles, or close friends might offer to help with childcare for siblings, prepare meals, or assist with transportation to medical appointments, which can be frequent for families in clinical trials.

Families should be aware that specialized centers focusing on hyperinsulinism are more likely to have clinical trials available. There are currently only a few centers worldwide with dedicated hyperinsulinism programs and the expertise to conduct research in this area[2]. Families may need to travel to access these centers, which adds additional logistical and financial burden, but these specialized programs also offer the most up-to-date knowledge and treatment approaches.

Connecting with other families affected by hyperinsulinism through support organizations can be invaluable. These connections allow families to share experiences, learn about clinical trials from those who have participated, and feel less isolated. Support groups, whether in person or online, provide a community of people who truly understand the unique challenges of living with this rare condition.

💊 Registered drugs used for this disease

List of officially registered medicines that are used in the treatment of this condition, based only on the provided sources:

  • Diazoxide – The only FDA-approved drug for treating hyperinsulinism, used to suppress insulin secretion and stimulate glucose release. It works by opening potassium channels in pancreatic beta cells. Diazoxide is considered an “essential medicine” by the World Health Organization.
  • Octreotide – A somatostatin analogue used when diazoxide is ineffective or when patients cannot tolerate it. It suppresses insulin secretion.
  • Lanreotide – Another somatostatin analogue used as an alternative treatment to suppress excessive insulin production.
  • Nifedipine – A calcium channel blocker used in some cases to help manage hyperinsulinism.
  • Sirolimus – A medication that has been used in treatment of certain forms of hyperinsulinism.
  • Glucagon – Used to stimulate glucose release in emergency situations or as part of ongoing management.

Ongoing Clinical Trials on Hyperinsulinism

  • Study on Ersodetug for Patients with Uncontrolled Low Blood Sugar Due to Tumor-Related High Insulin Levels

    Recruiting

    1 1 1
    Investigated diseases:
    France The Netherlands
  • Study on the Safety and Effects of Efpegerglucagon in Children Aged 2 and Older with Congenital Hyperinsulinism

    Recruiting

    1 1
    Investigated diseases:
    Investigated drugs:
    Germany
  • Study on RZ358 for Treating Congenital Hyperinsulinism in Patients

    Not recruiting

    1 1
    Investigated diseases:
    Bulgaria Denmark France Germany Greece Spain

References

https://pmc.ncbi.nlm.nih.gov/articles/PMC9538154/

https://www.pedsurglibrary.com/apsa/view/Pediatric-Surgery-NaT/829506/all/Congenital_Hyperinsulinism

https://pmc.ncbi.nlm.nih.gov/articles/PMC6735759/

https://www.webmd.com/children/congenital-hyperinsulinism

https://thekingsleyclinic.com/pancreas/hyperinsulinism-explained-symptoms-diagnosis-treatment-self-care/

https://emedicine.medscape.com/article/921258-treatment

https://pmc.ncbi.nlm.nih.gov/articles/PMC5790328/

https://www.texaschildrens.org/content/conditions/hyperinsulinism

https://www.chop.edu/conditions-diseases/congenital-hyperinsulinism

https://pmc.ncbi.nlm.nih.gov/articles/PMC11124746/

https://congenitalhi.org/hi-care-guidelines-simplified/

https://ojrd.biomedcentral.com/articles/10.1186/s13023-015-0367-x

https://my.clevelandclinic.org/health/diseases/24178-hyperinsulinemia

https://www.gosh.nhs.uk/health-professionals/living-hyperinsulinism/

https://www.youtube.com/watch?v=LdXoof0V44s

https://congenitalhi.org/hi-care-guidelines-simplified/

https://thekingsleyclinic.com/pancreas/hyperinsulinism-explained-symptoms-diagnosis-treatment-self-care/

https://www.checkupnewsroom.com/help-and-hope-for-hyperinsulinism/

https://pmc.ncbi.nlm.nih.gov/articles/PMC10546563/

https://www.healthline.com/health/hyperinsulinemia

https://www.chop.edu/conditions-diseases/congenital-hyperinsulinism

https://medlineplus.gov/diagnostictests.html

https://www.questdiagnostics.com/

https://www.healthdirect.gov.au/diagnostic-tests

https://www.who.int/health-topics/diagnostics

https://www.yalemedicine.org/clinical-keywords/diagnostic-testsprocedures

https://www.nibib.nih.gov/science-education/science-topics/rapid-diagnostics

https://www.health.harvard.edu/diagnostic-tests-and-medical-procedures

https://www.roche.com/stories/terminology-in-diagnostics

FAQ

How rare is congenital hyperinsulinism?

Congenital hyperinsulinism affects approximately 1 in 25,000 to 50,000 newborns, though some sources suggest it may occur in 1 in 20,000 to 30,000 babies. While it is rare, it is the most common cause of persistent and severe low blood sugar in infants and children.

Can my child outgrow hyperinsulinism?

It depends on the type. Transient hyperinsulinism, which can occur in premature babies or those whose mothers had diabetes during pregnancy, may resolve within weeks to months. However, genetic forms of hyperinsulinism typically persist and require ongoing treatment, though some children may achieve remission after years of medication and eventually stop needing treatment.

What is the difference between focal and diffuse hyperinsulinism?

In focal hyperinsulinism, only a small, isolated area of the pancreas is affected and produces too much insulin, while the rest of the pancreas functions normally. This can often be cured by surgically removing just that area. In diffuse hyperinsulinism, all the insulin-producing cells throughout the entire pancreas are affected, making treatment more complex.

Why is hyperinsulinism more dangerous than other causes of low blood sugar?

Because insulin not only lowers blood sugar but also blocks the body’s ability to produce ketones—alternative fuels the brain can use when glucose is low. This double effect means the brain has no fuel source at all during hypoglycemic episodes, making brain injury more likely and more severe compared to other causes of low blood sugar.

Will my child with hyperinsulinism develop diabetes after pancreatic surgery?

It’s possible. When a large portion of the pancreas is removed (near-total pancreatectomy), there is a risk that not enough insulin-producing tissue remains to regulate blood sugar normally, which can result in diabetes requiring insulin injections. However, this is often considered an acceptable trade-off for eliminating life-threatening hypoglycemia.

🎯 Key takeaways

  • Hyperinsulinism is the most common cause of severe, persistent low blood sugar in babies, yet it often goes undiagnosed because early symptoms look like typical newborn behavior.
  • Early diagnosis and aggressive blood sugar control are critical—every hypoglycemic episode puts a child’s developing brain at risk of permanent damage.
  • Focal hyperinsulinism can be completely cured with surgery to remove just the affected part of the pancreas, but it requires specialized imaging (PET scan) to locate the focal area.
  • Despite decades of research, there have been almost no new medications approved for hyperinsulinism since diazoxide was introduced in the 1960s.
  • Children with hyperinsulinism require extremely frequent feedings and cannot safely skip meals like healthy children, making daily life challenging for families.
  • Only a handful of specialized centers worldwide have the expertise to properly diagnose and treat hyperinsulinism, so families often need to travel for care.
  • With prompt treatment and good blood sugar control, many children with hyperinsulinism can develop normally and achieve typical cognitive and social skills.
  • Nearly half of all hyperinsulinism cases have no identifiable genetic cause, suggesting scientists still have much to learn about this condition.